neurodegenerative condition

source: pixabay.com

Arimoclomol Receives the Fast Track Designation for the Treatment of ALS

Post author:Kendall Mason
Post published:June 2, 2020
Post category:Amyotrophic Lateral Sclerosis Gaucher Disease Inclusion Body Myositis Niemann-Pick Disease

CytRx Corporation has recently received the Fast Track designation for their ALS treatment, arimoclomol. This status was also given for the treatment of Niemann-Pick disease and sporadic Inclusion Body Myositis…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More